These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1968288)

  • 1. Stereoselectivity in pharmacodynamics and pharmacokinetics.
    Ariëns EJ
    Schweiz Med Wochenschr; 1990 Feb; 120(5):131-4. PubMed ID: 1968288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stereochemistry--an overlooked problem in medical treatment and research].
    Mikkelsen EO
    Ugeskr Laeger; 1990 Jul; 152(28):2029-32. PubMed ID: 2195737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
    Elliott HL; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
    Honda K; Takenaka T; Miyata-Osawa A; Terai M
    J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of labetalol, propranolol and practolol in patients with asthma.
    Larsson K
    Eur J Respir Dis; 1982 May; 63(3):221-30. PubMed ID: 6124442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans.
    Boulton DW; Fawcett JP
    Clin Pharmacol Ther; 1997 Aug; 62(2):138-44. PubMed ID: 9284849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 9. Racemic therapeutics--ethical and regulatory aspects.
    Ariëns EJ
    Eur J Clin Pharmacol; 1991; 41(2):89-93. PubMed ID: 1743252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings].
    Harichaux P; Hary L
    Br J Pharmacol; 1976 Nov; 58(3):412P. PubMed ID: 11020
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
    Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
    J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol.
    Brizzi A; Brizzi V; Valoti M
    Farmaco; 2005 Feb; 60(2):105-11. PubMed ID: 15752469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R; Brocks DR
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
    Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C
    Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of dilevalol in histamine-induced airway constriction in guinea pigs].
    Iwasaki Y; Tsuya Y; Fujita E; Fujimoto T; Uenishi H; Touda Y; Hazu R; Tanaka A; Nagasaka Y; Nakajima S
    Arerugi; 1987 Sep; 36(9):848-54. PubMed ID: 2893598
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3',5'-monophosphate and DNA synthesis during liver regeneration.
    MacManus JP; Braceland BM; Youdale T; Whitfield JF
    J Cell Physiol; 1973 Oct; 82(2):157-64. PubMed ID: 4148138
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination.
    Lees P; Hunter RP; Reeves PT; Toutain PL
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():17-29. PubMed ID: 22413788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proxodolol--a new beta- and alpha-adrenoblockader].
    Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.